SureTrader SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Abattis Bioceuticals Corp. (ATTBF)

Add ATTBF Price Alert      Hide Sticky   Hide Intro
Moderator: Goodbuddy4863, guay, ebota12, GreenBrickRoad
Search This Board:
Last Post: 1/19/2017 9:29:20 PM - Followers: 275 - Board type: Free - Posts Today: 0


Welcome to Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQB: ATTBF) (CSE: ATT), is a specialty biotechnology company with capabilities through its wholly-owned subsidiaries as a botanical drug development company that develops and licenses natural health products, medicines, extractions and ingredients for the biologics, nutraceutical, bioceutical and cosmetic markets, some of which will contain cannabinoid compounds. Abattis develops and is in the process of commercializing natural health products that target ailments and satisfy important market needs. Abattis is conducting ongoing research and development to create plant-based intellectual property and ingredients. Current areas of focus are growth through acquisition and business development and cash flow through commercialization of existing assets.

Through our divisions Biocell Labs Inc. and Vergence Sales & Marketing Group, we develop and license natural health products and have future plans to expand into the nutraceutical, pharmaceutical and cosmetic markets. The Company has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding natural health product market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions.

Within our other divisions Northern Vine, North American Bioextracts and Biocube, as well as investments we have made in companies such as Phytalytics (51%), IPS (51%) and Experion (25%), we have capabilities that support the production and extraction of botanical ingredients for our products; one of which includes cannabis.

Northern Vine LaboratoriesTM (Northern Vine Labs
TM) seeks to become the premier analytical testing laboratory, and research and development partner to the legal cannabis industry in Canada - Executive Overview

For more information, visit the Company's website at:

Our investors are forward thinkers in the emerging bioceutical and medical marijuana markets. We are a specialty, vertically-integrated biotechnology company that aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. From patented and proprietary formulations, extraction and processing methods, Abattis consistently seeks opportunities to participate in varied markets all connected by a common global purpose and customer base: seeking health through natural products. Abattis is uniquely positioned to fully exploit the growing trend toward marijuana legalization in the United States and medicinal use in Canada as licensed and international jurisdictions.

“Health Canada estimates that the emerging medical marijuana market to be in excess of $1 billion.
Stephen Easton, an SFU Economist, estimated that nationally the Cannabis industry generates approximately $19 to $21 billion”

We develop and license natural health products with unique botanical blends, CBD and proprietary ingredients. These infused food and beverage brands are designed for wellness nutraceuticals, medical foods & botanical drugs market with future plans to expand into the pharmaceutical and cosmetic markets.

As an investor, you are our partner and we take this relationship seriously. Please contact us if you have any questions or if you would like to invest in Abattis.


Goldman Small Cap Research report, 'This Stock Set to Double Thanks to New License'
Abattis Bioceuticals Corp. - Stock Up Big on Recent News, Greater Gains on Horizon (October 20, 2016).

Goldman Small Cap Research report 
'The Next Industry-Changing Specialty Health Stock'
Abattis Bioceuticals Corp. - Major Revenue Ahead for Innovative, Diversified Bioceuticals Pioneer (June 13, 2016).


Northern Vine
Phone: (604) 371.3371 | 
(604) 316.0982 (604) 888.1129

CHINA | Dr. Shuang Xie  Ph. D.
Suzhou Raybot Material Tech Ltd
T: 17785884380 | C: 17783175968
Phone: 86 5125240581 | 8613901388668
Address:  No. 10-1 Yang Yuan Road,
Xinzhuang Zhen,Changshu | China


Listing date: 12/23/2010
Issued & Outstanding: 
(Effective: 12/07/2016)

Consolidated Financial Statements
For the three and nine months ended June 30, 2016

System for Electronic Document Analysis and Retrieval (SEDAR) -

12/16/2016 | Abattis Provides Corporate Update
12/09/2016 | Abattis Bioceutical Inks $ 5 Million Facility with Aluminia Partners
11/15/2016 | Abattis Announces the Appointment of Dr. Shuang Xie as Director and Chief Technology Advisor
11/09/2016 | Abattis Announces Licensing Deal and Brand Acouisition
11/07/2016 | Abattis Announces Renewal of Health Canada Licence
11/02/2016 | Abattis Announces the Appointment of New Independent Director
10/24/2016 | Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc.
10/17/2016 | Abattis Bioceuticals Corp.: Experion Biotechnologies Prepares for Construction
10/05/2016 | Abattis Signs MOU with Global Damon Pharma of South Korea
10/03/2016 | Abattis' Northern Vine Labs Receives Controlled Substance Licence

If you want to add or to change something on this site - send a message to guay.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ATTBF News: Withdrawal of Registration Statement (rw) 12/09/2016 06:05:17 AM
#27521   Compare ATTBF with AXI#, one has Vitagum, and all4weed 01/19/17 09:29:20 PM
#27284  Sticky Note Goldman Research thinks ATTBF could blow through $0.30+ GreenBrickRoad 10/21/16 11:19:22 AM
#27151  Sticky Note Abattis Bioceuticals (ATTBF) Experion Biotechnologies Prepares for Construction guay 10/17/16 10:22:27 AM
#27144  Sticky Note 'The Next Industry-Changing Specialty Health Stock' guay 10/14/16 04:30:32 PM
#26399  Sticky Note Corporate Update ebota12 11/05/15 07:31:44 PM
#12064  Sticky Note BOARD WARNING - Please Read: IH Admin [Shelly] 06/09/14 01:18:32 PM
#27520   Agree ! guay 01/19/17 03:50:18 PM
#27519   Next filing we'll read about issuing 25,000 shares ebota12 01/18/17 08:55:18 PM
#27518   Insiders acquiring common shares is always a good sign oatsuzn 01/18/17 05:22:59 PM
#27517   Abattis Bioceuticals Corp (ATTBF) Insider Rene David Acquires Hawk-02 01/18/17 04:29:02 PM
#27516   Thanks Quay! Goodbuddy4863 01/17/17 06:16:46 PM
#27515   Sure seems that way. Also seems he made GreenBrickRoad 01/17/17 03:16:56 PM
#27514   … so it seems - 10.000 CAD-$ … guay 01/17/17 10:42:37 AM
#27513   Maybe I don't understand the format of this ebota12 01/17/17 10:22:52 AM
#27512   Abattis Bioceuticals Corp. C:ATT - Insider Filings guay 01/17/17 08:27:46 AM
#27511   About Green Nature Health Care Products guay 01/17/17 07:37:05 AM
#27510   Abattis provides an update to its shareholders guay 01/17/17 07:31:43 AM
#27509   'Hawk-02' Allow me to give you a primer Shaark 01/13/17 01:09:37 PM
#27508   OK SHAARK! I'm In.. LETS DO THIS. Looking Hawk-02 01/13/17 09:47:53 AM
#27507 Oiler84 01/12/17 04:57:53 PM
#27506   Another dragonfly doji $ATTBF jjr04001 01/11/17 04:30:00 PM
#27505   This is going to be a monster!! Verge make it happen 01/10/17 05:17:05 PM
#27504   Agree, though "eventually" could be a long time. GreenBrickRoad 01/10/17 11:20:33 AM
#27503   Hey the set up but in it georgie18 01/09/17 07:18:26 AM
#27502   georgie in da hooouuuusssee $ATTBF jjr04001 01/09/17 07:09:40 AM
#27501   The sooner the better. Goodbuddy4863 01/07/17 09:55:43 PM
#27500   That is eventually going to change because most RickJames23 01/07/17 09:04:20 PM
#27499   Donald Trump's advisor Peter Thiel has millions invested RickJames23 01/07/17 08:56:24 PM
#27498   Yes, I thought if Northern Vine could obtain Goodbuddy4863 01/06/17 01:07:32 PM
#27497   ATTBF... 1124...Chart...Bollies real tight here...Breakout setting up... georgie18 01/06/17 09:44:28 AM
#27496   ATTBF is one of the very few MJ Shaark 01/06/17 09:43:01 AM
#27495   Abattis Bioceuticals’ (ATTBF) Northern Vine Labs Could Benefit guay 01/06/17 06:43:14 AM
#27494   Great thinking. Goodbuddy4863 01/05/17 10:24:14 PM
#27493   agree GreenBrickRoad! guay 01/05/17 05:45:29 PM
#27492   This confirms Northern Vine has one Lab open: Goodbuddy4863 01/05/17 03:07:24 PM
#27491   BTW Happy New Year everyone. 2017 is GreenBrickRoad 01/05/17 01:41:21 PM
#27490   That information has become quite repetitive, I'll give GreenBrickRoad 01/05/17 01:38:20 PM
#27489   Interesting. Looking at the last part of GreenBrickRoad 01/05/17 01:29:42 PM
#27488   Yes you have, the same information has been ebota12 01/05/17 01:22:11 PM
#27487   I had not seen this News. Goodbuddy4863 01/05/17 10:45:16 AM
#27486   News: Abattis Bioceuticals (ATTBF) Northern Vine Labs and jjr04001 01/05/17 09:12:16 AM
#27485   Donald Trump's Stance On Marijuana Could Cause 'Discomfort' guay 01/04/17 11:38:54 AM
#27484   $2.78 January 2014 repeating history :) ATTBF BOOM BABY make it happen 12/30/16 03:57:34 PM
#27483   Load up! Pennymonsters 12/30/16 03:53:01 PM
#27482   i am trying to be conservative, just add AAAtrades 12/30/16 11:51:03 AM
#27481   Why so low? ebota12 12/30/16 08:41:01 AM
#27480   The year ahead is expected to be a AAAtrades 12/29/16 01:20:09 PM
#27479   since the new year is close at hand, AAAtrades 12/29/16 01:10:18 PM
#27478   ATTBF has a lot of good news that's unnoticed. KUMO TWIST 12/28/16 07:58:21 PM
#27477   I'll be here. Goodbuddy4863 12/28/16 03:10:24 PM
#27476   Abattis Bioceuticals inks $5 mln facility with Alumina Partners guay 12/28/16 02:52:33 PM
#27475   50ma break coming. Should move well soon. KUMO TWIST 12/28/16 02:33:27 PM
#27474   Informational Purposes Only: Goodbuddy4863 12/28/16 02:15:08 PM
#27473   Yes, for way too Long. Goodbuddy4863 12/28/16 10:43:08 AM
#27472   Northern Vine LaboratoriesTM (Northern Vine LabsTM) seeks to Goodbuddy4863 12/28/16 10:41:51 AM